Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lad

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Physical Review. E|July 20, 2022
Brownian motion with time-dependent friction and single-particle dynamics in liquidsKirit N Lad, Margi K Patel, Arun Pratap
Thrombosis Research|May 15, 1987
The effect of thromboxane A2 synthesis inhibitors on platelet aggregation in whole bloodN Lad, D O Lunt, D P Tuffin
The European Physical Journal. E, Soft Matter|June 20, 2026
Semi-analytical modeling and simulation of human red blood cell deformation under non-linear strainGaurav D Bhabhor, Rishabh Bhatt, Arun Anand, et al.
European Journal of Pharmacology|November 1, 1994
Assessment of myeloperoxidase activity in renal tissue after ischemia/reperfusionD W Laight, N Lad, B Woodward, et al.
Physical Review. E|October 18, 2023
Reply to "Comment on 'Brownian motion with time-dependent friction and single-particle dynamics in liquids' "Kirit N Lad, Margi K Patel, Arun Pratap, et al.
Thrombosis Research|January 15, 1986
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human plateletsP J Wade, D O Lunt, N Lad, et al.
British Journal of Pharmacology|February 1, 1989
Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivoR F Booth, A C Honey, N Lad, et al.
Voprosy Meditsinskoi Khimii|March 10, 2001
[The pathogenetic significance of disruption of antioxidant homeostasis status in patients with hypertension]A V Paranich, S N Lad, N A Frolova, et al.
Thrombosis and Haemostasis|April 8, 1988
Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivoN Lad, A C Honey, D O Lunt, et al.
Biochemical Pharmacology|November 15, 1990
A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activityR F Booth, D O Lunt, N Lad, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Physical Review. E|July 20, 2022
Brownian motion with time-dependent friction and single-particle dynamics in liquidsKirit N Lad, Margi K Patel, Arun Pratap
Thrombosis Research|May 15, 1987
The effect of thromboxane A2 synthesis inhibitors on platelet aggregation in whole bloodN Lad, D O Lunt, D P Tuffin
The European Physical Journal. E, Soft Matter|June 20, 2026
Semi-analytical modeling and simulation of human red blood cell deformation under non-linear strainGaurav D Bhabhor, Rishabh Bhatt, Arun Anand, et al.
European Journal of Pharmacology|November 1, 1994
Assessment of myeloperoxidase activity in renal tissue after ischemia/reperfusionD W Laight, N Lad, B Woodward, et al.
Physical Review. E|October 18, 2023
Reply to "Comment on 'Brownian motion with time-dependent friction and single-particle dynamics in liquids' "Kirit N Lad, Margi K Patel, Arun Pratap, et al.
Thrombosis Research|January 15, 1986
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human plateletsP J Wade, D O Lunt, N Lad, et al.
British Journal of Pharmacology|February 1, 1989
Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivoR F Booth, A C Honey, N Lad, et al.
Voprosy Meditsinskoi Khimii|March 10, 2001
[The pathogenetic significance of disruption of antioxidant homeostasis status in patients with hypertension]A V Paranich, S N Lad, N A Frolova, et al.
Thrombosis and Haemostasis|April 8, 1988
Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivoN Lad, A C Honey, D O Lunt, et al.
Biochemical Pharmacology|November 15, 1990
A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activityR F Booth, D O Lunt, N Lad, et al.
Pageof 8